Anti-HA tag Antibody

Price:
Size:
Number:

Anti-HA tag Antibody (Mouse Monoclonal antibody) General Information

Product name
Anti-HA tag Antibody
Validated applications
WB,ELISA,FCM,ICC/IF,IF,IP
Specificity
HA tag
Immunogen
A synthetic peptide corresponding to the HA-tag sequence (YPYDVPDYA).
Preparation
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, a synthetic peptide corresponding to the HA-tag sequence. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Source
Monoclonal Mouse IgG1 Clone #10
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Concentration
0.5 μl/Test
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Anti-HA tag Antibody (Mouse Monoclonal antibody) Validated Applications

Application Dilution
WB 1/2000-1/5000
ELISA 1/2000-1/5000
ICC-IF 1/200-1/500
IP 2-8 μL/mg of lysate
Please Note: Optimal concentrations/dilutions should be determined by the end user.

Anti-HA tag Antibody (Mouse Monoclonal antibody) Images

This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect HA-tagged protein (amino-terminus HA tag or carboxy-terminus HA tag).
Profile of anti-HA Tag reactivity on 293 transfected cells analyzed by flow cytometry. 293 cells transfected with HA-ARG1 (Figure A), HA-mFABP4 (Figure B), ARG1-HA (Figure C) and mFABP4-HA (Figure D) were fixed and permeabilized according to the manufacturer's manual (Cat. No. 554714,BD Pharmingen) and subsequently stained with Purified Mouse Anti-HA Tag antibody (Cat No. 100028-MM10) Or positive control antibody  for 30 min on ice. Cells were washed twice and incubated with 1 μg of a FITC Goat Anti-Mouse Ig secondary antibody for 30 min on ice. Cells were washed twice and analyzed by flow cytometry.
Immunofluorescence staining of HA-Tag in 293 cells, transfected with HA-ARG1 (L) or mock-transfected (R). Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with SBI Mouse anti-HA-tag monoclonal antibody at 37℃ 1 hour. Then cells were stained with the Alexa Fluor® 488-conjugated Goat Anti-mouse IgG secondary antibody (green).
Immunofluorescence staining of HA-Tag in 293 cells, transfected with HA-ARG1 (Figure A), HA-mFABP4 (Figure B), ARG1-HA (Figure C) and mFABP4-HA (Figure D). Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with Mouse anti-HA-Tag monoclonal antibody at 37℃ 1 hour. Then cells were stained with the Alexa Fluor® 488-conjugated Goat Anti-mouse IgG secondary antibody (green) and counterstained with DAPI (blue).

Anti-HA Tag was immunoprecipitated using:

Lane A: HA-ARG1-myc transfected 293 cell lysate (0.5mg)

Lane B: myc-ARG1-HA transfected 293 cell lysate (0.5mg)

2 μL anti-HA Tag mouse monoclonal antibody and 60 μg of Immunomagnetic beads Protein G.

Primary antibody:

Anti-HA Tag rabbit monoclonal antibody, at 1:100 dilution

Secondary

Goat Anti-Mouse IgG H&L (Dylight800) at 1/15000 dilution.

Developed using the Odyssey technique.

Performed under reducing conditions.

Anti-HA Tag mouse monoclonal antibody at 1:1000 dilution

Lane A: HA-GST (Recombinant protein)(30ng)

Lane B: GST-HA (Recombinant protein)(10ng)

Lane C: HA-ARG1-myc transfected 293 cell lysate (2ug)

Lane D: HA-mFABP4-myc transfected 293 cell lysate (2ug)

Lane E: myc-mFABP4-HA transfected 293 cell lysate (0.5ug)

Lane F: myc-ARG1-HA transfected 293 cell lysate (2ug)

Secondary

Goat Anti-Mouse IgG H&L (Dylight800) at 1/15000 dilution.

Developed using the Odyssey technique.

Performed under reducing conditions.

  • Infection-derived lipids elicit an immune deficiency circuit in arthropods
    Author
    Shaw, DK;Wang, X;Brown, LJ;Chávez, AS;Reif, KE;Smith, AA;Scott, AJ;McClure, EE;Boradia, VM;Hammond, HL;Sundberg, EJ;Snyder, GA;Liu, L;DePonte, K;Villar, M;Ueti, MW;de la Fuente, J;Ernst, RK;Pal, U;Fikrig, E;Pedra, JH;
    Year
    2017
    Journal
    Nat Commun
    Application
    WB/IP
Add to Cart Successfully Add to Cart Failed